Mark Salvati
Impact in
-
- Hormonal and reproductive studies
- Genetics top 5%
- Estrogen and related hormone effects
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 12
-
- Prostate Cancer Treatment and Research 11
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Ricardo M. Attar (10 shared papers)Roberto Weinmann (5 shared papers)Stanley R. Krystek (6 shared papers)John S. Sack (3 shared papers)Yongmi An (3 shared papers)Michael Nguyen (1 shared paper)Robert W. Armstrong (1 shared paper)Kevin Kish (2 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Blood (4 papers)Tetrahedron Letters (2 papers)The Prostate (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Mark Salvati
45 papers receiving 996 citations
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 359
- Genetics 357
- Pulmonary and Respiratory Medicine 403
- Organic Chemistry 191
- Oncology 174
Countries citing papers authored by Mark Salvati
This map shows the geographic impact of Mark Salvati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Salvati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Salvati more than expected).
Fields of papers citing papers by Mark Salvati
This network shows the impact of papers produced by Mark Salvati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Salvati. The network helps show where Mark Salvati may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Salvati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 357 | |
| 2 | 1992 | 100 | |
| 3 | 2010 | 92 | |
| 4 | 2004 | 48 | |
| 5 | 2006 | 46 | |
| 6 | 2009 | 38 | |
| 7 | 2004 | 33 | |
| 8 | 2010 | 26 | |
| 9 | 2004 | 25 | |
| 10 | 2005 | 22 | |
| 11 | 2018 | 21 | |
| 12 | 2008 | 20 | |
| 13 | 2007 | 20 | |
| 14 | 2007 | 19 | |
| 15 | 2020 | 19 | |
| 16 | 2018 | 14 | |
| 17 | 2014 | 12 | |
| 18 | 2012 | 11 | |
| 19 | 2021 | 11 | |
| 20 | 2021 | 10 |
About Mark Salvati
Mark Salvati is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (12 papers), Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (9 papers), Estrogen and related hormone effects (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (359 citations), Genetics (357 citations), Pulmonary and Respiratory Medicine (403 citations), Organic Chemistry (191 citations) and Oncology (174 citations). Mark Salvati has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ricardo M. Attar, Roberto Weinmann, Stanley R. Krystek, John S. Sack, Yongmi An, Michael Nguyen, Robert W. Armstrong, Kevin Kish, Chihuei Wang and Julie E. Scheffler. Their work appears in journals such as Journal of Clinical Oncology, Bioorganic & Medicinal Chemistry Letters, Blood, Tetrahedron Letters and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.